CTRI/2025/11/097050尚未招募2 期
A clinical study on the effect of vanapalandu in kaphaja hridroga with special reference to low left ventricular ejection fraction A proof of concept study
National Institute of Ayurveda Jaipur1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2026年3月20日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Change present in ejection fraction in 2D echocardiography of the heart after 2
研究概览
简要总结
A Clinical Study on the Effect of Vanapalandu in Kaphaja Hridroga with Special Reference to Low Left Ventricular Ejection Fraction: A Proof of Concept Study”
this study Aims for improvement in reduced ejection fraction of heart by giving Vanapalandu 90mg twice a day for 60 days.
outcomes are - improved ejection fraction assessing by 2D Echo by 60 days.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 59.00 Year(s)（—）
- 性别
- All
入选标准
- •Adult patients of both genders, with stable HF (NYHA classification up to Class III and reduced EF not more than 40% and not less than 15%.
- •Patients who have already taken conventional therapy for more than or equal to 3 months and yet have the above criteria would also be included.
排除标准
- •1.Patients with an Ejection Fraction of the Left Ventricle more than or equal to 40 percent and less than or equal to 15 percent will not be included in the study.
- •2.Patients with a history of Unstable Angina, Acute Myocardial infarction (newly diagnosed acute cases), valvular defects, congenital heart disease, pericarditis, arrhythmia, Pericardial effusion, uncontrolled Hypertension (more than or equal to 150/90 mm Hg) 3.Patients with a history of extra Cardiac ailments like renal failure, uncontrolled diabetes mellitus (HbA1c more than or equal to 8%) with or without complications, chronic alcoholics, and pregnant/lactating women.
结局指标
主要结局
Change present in ejection fraction in 2D echocardiography of the heart after 2
时间窗: 2 months
months of trial.
时间窗: 2 months
次要结局
- • Changes in signs and symptoms of Kaphaja Hridroga after 2 months of trial.(• Changes in symptoms using a standardized tool, the KCC Questionnaire after 2)
研究者
Dr Falguni Joshi
national institute of ayurveda
研究点 (1)
Loading locations...
相似试验
尚未招募
Phase 3 4
A Study Comparing Ayurvedic Herbal Smoke Therapy and Oxygen Exposure Therapy For Faster Healing of Diabetic Foot UlcerCTRI/2025/11/097191Dr Jignesh Babubharthi Goswami32
尚未招募
2 期
Use and effect of Vriddhadarvadya Lauha In Amavata Rheumatoid arthritisCTRI/2025/11/096773Madan Mohan Malviya Government Ayurved College Udaipur60
尚未招募
1/2 期
A efficacy study of an Ayurvedic Decoction (Kadha) Varadi Kashaya to reduce HbA1c in patients of Type 2 Diabetes Mellitus as compared to Standard MedicationsCTRI/2025/12/099036Bharati Vidyapeeth Deemed to be University College of Ayurved30
尚未招募
2 期
To Study The Effect Of Krimighanadi Kashaya In ObesityCTRI/2025/12/098982Jammu Institute Of Ayurveda And Research30
招募中
2 期
Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS)Heart FailureNCT07304817University Medical Center Groningen100